Search This Blog

 


C

o

l

l

o

i

d

o

n

c

o

t

i

c

p

r

e

s

s

u

r

e

(

C

O

P

)

,

3

5

3

C

o

l

l

o

i

d

s

,

3

5

8

3

5

9

c

o

mp

o

s

it

io

n

a

n

d

p

r

op

e

r

t

ie

s

o

f,

3

5

4

t

v

s. c

r

y

s

t

a

llo

id

s

,

3

5

3

3

5

4

C

o

l

o

n

c

a

n

c

e

r

,

2

0

7

0

2

0

8

2

c

h

e

mo

th

e

r

a

p

y

fo

r

,

2

0

7

3

2

0

7

7

c

linic

a

l

p

r

e

s

e

nt

a

t

io

n

o

f,

2

0

7

1

,

2

0

7

3

c

linic

a

l

s

ur

v

e

illa

n

c

e

fo

r

r

e

c

ur

r

e

n

c

e

,

2

0

7

7

2

0

7

8

dia

gn

o

s

is

o

f,

2

0

7

1

e

p

id

e

mio

lo

gy

o

f,

2

0

7

1

e

t

io

lo

gy

o

f,

2

0

7

1

2

0

7

2

fo

r

me

t

a

s

t

a

t

ic

,

2

0

7

8

2

0

7

9

n

e

o

a

dj

uv

a

nt

,

2

0

8

2

p

a

th

op

hy

s

io

lo

gy

o

f,

2

0

7

1

a

n

d

p

e

r

ip

h

e

r

a

l

n

e

ur

op

a

thy

,

2

0

7

7

p

r

e

dic

t

iv

e

ma

r

ke

r

s

,

2

0

7

7

s

c

r

e

e

nin

g

,

2

0

7

2

s

it

e

s

o

f

me

t

a

s

t

a

s

e

s

,

1

9

5

0

t

th

e

r

a

p

e

ut

ic

mo

d

a

lit

ie

s

,

2

0

7

1

c

h

e

mo

th

e

r

a

p

y

,

2

0

7

3

2

0

7

7

d

e

r

ma

t

o

lo

g

ic

t

o

x

ic

ity

r

e

la

t

e

d

t

o

E

GF

R

th

e

r

a

p

y

,

2

0

7

9

h

e

p

a

t

ic

me

t

a

s

t

a

s

e

s

,

2

0

7

9

in

fu

s

io

n

-

r

e

la

t

e

d

r

e

a

c

t

io

n

s

,

2

0

8

1

n

e

o

a

dj

uv

a

nt

c

h

e

mo

th

e

r

a

p

y

,

2

0

8

2

s

e

le

c

t

e

d

r

e

g

ime

n

s

,

2

0

7

4

t–

2

0

7

5

t

C

o

l

o

n

i

z

a

t

i

o

n

,

1

3

3

1

C

o

l

o

r

a

d

o

t

i

c

k

fe

v

e

r

(

C

T

F

)

dia

gn

o

s

is

o

f,

1

7

2

8

h

o

s

t

r

e

s

e

r

v

o

ir

s

,

1

7

2

7

1

7

2

8

id

e

nt

ific

a

t

io

n

o

f

v

iru

s

,

1

7

2

7

1

7

2

8

la

b

o

r

a

t

o

r

y

fin

din

g

s

,

1

7

2

8

a

n

d

le

ukop

e

nia

,

1

7

2

8

p

r

e

v

a

le

n

c

e

o

f,

1

7

2

8

s

upp

o

r

t

iv

e

c

a

r

e

,

1

7

2

8

s

ymp

t

o

m

s

o

f,

1

7

2

8

t

ic

k

s

p

e

c

ie

s

,

1

7

2

7

1

7

2

8

tr

e

a

tme

nt

c

a

r

e

,

1

7

2

8

C

o

l

o

r

a

d

o

t

i

c

k

fe

v

e

r

v

i

r

u

s

(

C

T

F

V)

,

1

7

2

7

C

o

l

o

r

e

c

t

a

l

c

a

n

c

e

r

A

me

r

ic

a

n

C

a

n

c

e

r

S

o

c

ie

ty

S

c

r

e

e

nin

g

R

e

c

o

mme

n

d

a

t

io

n

,

2

0

7

2

t

c

h

e

mo

th

e

r

a

p

y

fo

r

,

2

0

7

8

c

o

lo

n

c

a

n

c

e

r

,

2

0

7

0–

2

0

8

2

E

GF

R

r

e

c

e

p

t

o

r

,

2

0

7

9

immun

o

th

e

r

a

p

y

,

2

0

7

9

a

n

d

p

o

s

tme

n

op

a

u

s

a

l

h

o

r

mo

n

e

th

e

r

a

p

y

,

1

0

3

1

t

r

e

c

tum

c

a

n

c

e

r

,

2

0

8

1

2

0

8

2

s

a

lv

a

g

e

th

e

r

a

p

y

,

2

0

8

1

C

o

l

o

r

e

c

t

a

l

s

u

r

g

e

ry

,

p

r

o

p

h

yl

a

x

i

s

fo

r

,

1

3

4

5

t

C

o

m

b

A

T

(

s

e

e

C

o

m

b

i

n

a

t

i

o

n

o

f

A

v

o

d

a

rt

a

n

d

T

a

m

s

u

l

o

s

i

n

(

C

o

m

b

A

T

)

)

C

o

m

b

i

n

a

t

i

o

n

A

s

s

e

s

s

m

e

n

t

o

f

R

a

n

o

l

azi

n

e

i

n

S

t

a

b

l

e

A

n

g

i

n

a

(

C

A

R

I

S

A

)

,

2

2

3

C

o

m

b

i

n

a

t

i

o

n

o

f

A

v

o

d

a

rt

a

n

d

T

a

m

s

u

l

o

s

i

n

(

C

o

m

b

A

T

)

,

2

2

5

8

C

o

m

b

i

n

a

t

i

o

n

t

h

e

r

a

p

y

,

4

6

0

p. 2

3

3

1

No comments:

Post a Comment

اكتب تعليق حول الموضوع

mcq general

 

Search This Blog